Fingerprint
Dive into the research topics of 'Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
the C-TEAM study group and the Taiwan Liver Diseases Consortium
Research output: Contribution to journal › Article › peer-review
127
Citations
(Scopus)